Carboplatin/Paclitaxel/Pembrolizumab Regimen

Preferred Label : Carboplatin/Paclitaxel/Pembrolizumab Regimen;

NCIt synonyms : Carboplatin-Paclitaxel-Pembrolizumab; Carboplatin/Paclitaxel/Pembrolizumab; Carboplatin-Paclitaxel-Pembrolizumab Regimen; Carboplatin/Taxol/Keytruda;

NCIt related terms : Carboplatin and Paclitaxel (CP) and Pembrolizumab;

NCIt definition : A regimen consisting of carboplatin, paclitaxel, and pembrolizumab that can be used in the treatment of breast cancer, cervical cancer, vaginal cancer, vulvar cancer, endometrial carcinoma, head and neck cancers, and metastatic squamous non-small cell lung cancer (NSCLC). Pembrolizumab plus paclitaxel weekly/carboplatin regimen may be used for the treatment of head and neck cancers.;

NCI Metathesaurus CUI : CL936979;

Codes from synonyms : 30172;

Details

Origin ID

C157396;

UMLS CUI

C4763594;

See also (suggested by CISMeF)
- Metastatic Lung Non-Small Cell Squamous Carcinoma [NCIt concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Carboplatin [NCIt concept]
- Paclitaxel [NCIt concept]
- Pembrolizumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients